Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 8Unknown 2Withdrawn 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 31Lymphoma 18Lymphoma, Large B-Cell, Diffuse 17Sarcoma 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Neoplasm Metastasis 10Hodgkin Disease 9Lymphoma, Non-Hodgkin 8Recurrence 7Prostatic Neoplasms 7Neoplasms 7Multiple Myeloma 7Burkitt Lymphoma 7Ovarian Neoplasms 6Leukemia 6Lymphoma, B-Cell 5Fallopian Tube Neoplasms 5Cardiotoxicity 5Carcinoma, Hepatocellular 5Urinary Bladder Neoplasms 4Osteosarcoma 4Liver Neoplasms 4Triple Negative Breast Neoplasms 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Lymphoma, Follicular 3Leukemia, Myeloid, Acute 3Leukemia, Biphenotypic, Acute 3Colonic Neoplasms 3Waldenstrom Macroglobulinemia 2

Interventions

Ifosfamide 3Etoposide 3Thiotepa 2Stem Cell Transplantation 2Radiotherapy 2Melphalan 2Irinotecan 2Filgrastim 2thymoglobulin 1temsirolimus 1sargramostim 1robatumumab 1omburtamab I-131 1fludarabine phosphate 1etoposide phosphate 1Valproic Acid 1Temozolomide 1Tacrolimus 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Neoadjuvant Therapy 1Mycophenolic Acid 1Microarray Analysis 1Mesna 1Immunohistochemistry 1Immunoenzyme Techniques 1Granulocyte Colony-Stimulating Factor 1FANG vaccine 1Doxorubicin 1Dexrazoxane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Neuroectodermal Tumors, Primitive, Peripheral × Doxorubicin × Clear all
NCT00544778 2014-08-28

Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone Sarcoma

City of Hope Medical Center

Phase 2 Terminated
7 enrolled 2 charts
Sarcoma

Sarcoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡